💼 Business
3d ago
Novo CEO tells CNBC why drugmaker is rebranding, needs to 'rethink' obesity strategy
Source ↗
👁 1
💬 0
The Danish drugmaker called the changes the beginning of a new chapter for the company, which faces stiff competition from Eli Lilly.
Comments (0)